to make no practical suggestions as to how to increase screening coverage. SECTION 2: Invalid and unsatisfactory cervical screening results Name / Title Organisation Feedback Aroha Morgan, Maori Health, Lakes Non applicable from a non-clinical perspective. Phyllis Tangitu and District Health Board Trish Solomon Dr Vicki Robertson, West Coast DHB No additional comments. We support these recommendations. Lead Colposcopist Beth Henderson, Well Women & Good. Education Nurse Family Trust Waikato DHB Good to give time frame for repeat testing and great to see recommendation for use of vaginal oestrogen in post-menopausal women Need to ensure there are no CONTRA-INDCATIONS before prescribing (eg – history of oestrogen sensitive tumours such as breast cancer). – Other evidence/information to consider: P10 amendment: Pip Egerton, Rural Tuatapere and Good to see 2.04 included. Practice Nurse Otautau Medical (smear taker), Centre evidence/information to consider: Primary Care Good to see this removed as a Quality measure for cervical smear takers representative Otago / Southland NCSP regional MDT Fiona Moscrop on Compass Health Acceptable. – behalf of Clinical Quality Board Respondent’s name Member of the In my opinion postmenopausal women should be offered self HPV testing in the first instance rather than redacted at request. public vaginal oestrogen when a test is invalid. CWH & CHL - Refer Collaborative Support recommendations. Section 1 feedback CWH and CHL
to make no practical suggestions as to how to increase screening coverage. SECTION 2: Invalid and unsatisfactory cervical screening results Name / Title Organisation Feedback Aroha Morgan, Phyllis Tangitu and Trish Solomon Maori Health, Lakes District Health Board Non applicable from a non-clinical perspective. Dr Vicki Robertson, Lead Colposcopist West Coast DHB No additional comments. We support these recommendations. Beth Henderson, Education Nurse Well Women & Family Trust Good. Waikato DHB Good to give time frame for repeat testing and great to see recommendation for use of vaginal oestrogen in post-menopausal women – Need to ensure there are no CONTRA-INDCATIONS before prescribing (eg history of oestrogen sensitive tumours – such as breast cancer). Other evidence/information to consider: P10 amendment: Pip Egerton, Rural Practice Nurse (smear taker), Primary Care representative Otago / Southland NCSP regional MDT Tuatapere and Otautau Medical Centre Good to see 2.04 included. evidence/information to consider: Good to see this removed as a Quality measure for cervical smear takers Fiona Moscrop – on behalf of Clinical Quality Board Compass Health Acceptable. Respondent’s name redacted at request. Member of the public In my opinion postmenopausal women should be offered self HPV testing in the first instance rather than vaginal oestrogen when a test is invalid. CWH & CHL - Refer Section 1 Collaborative feedback CWH and CHL Support recommendations.
consultation-feedback-uupdated-clinical-practice-guidelines-cervical-screening-nz-aug17.docx